Brief: Medipharm Labs Enters Into New Supply Agreement With Dancann Pharma
Sept 25 (Reuters) - Medipharm Labs Corp LABS.TO :
* MEDIPHARM LABS EXPANDS DENMARK REVENUE OPPORTUNITY, ENTERS
NEW
SUPPLY AGREEMENT WITH DANCANN PHARMA
* MEDIPHARM LABS CORP - HAS ENTERED INTO A NEW WHITE-LABEL
SUPPLY
AGREEMENT WITH DANCANN PHARMA A/S
* MEDIPHARM LABS CORP - WILL SUPPLY A FULL RANGE OF
SPECIALLY
FORMULATED CBD AND THC CANNABIS OIL PRODUCTS THAT WILL BE
WHITE-LABELED FOR DISTRIBUTION
Source text for Eikon: ID:nGNX15dTcL
Further company coverage: LABS.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Medipharm Labs
See all newsCanada's MediPharm Labs Q2 revenue rises 11% on international growth
Brief: MediPharm Labs Q2 Revenue CAD 10 Million
Canada's MediPharm Labs reports positive Q1 adjusted EBITDA
Canada's MediPharm Labs FY revenue rises 8% on international sales
Brief: Medipharm Labs Reports Full Year & Fourth Quarter 2025 Results With Over 40% Annual Growth In International Medical Revenue